Health News 

Impact of metabolic syndrome on severity of COVID-19 illness

hypertension

Patients with metabolic syndrome have significantly worse hospitalization and mortality rates due to COVID-19. Hypertension, diabetes, and obesity are common comorbidities associated with metabolic syndrome, as described in a new study published in the peer-reviewed journal Metabolic Syndrome and Related Disorders.

“Our results demonstrate that patients with metabolic syndrome were 77% more likely to be hospitalized, 56% more likely to be admitted to the intensive care unit, and 81% more likely to die from COVID-19, according to Sangeeta Kashyap, MD, from the Cleveland Clinic, and coauthors. “Obesity, hyperglycemia, dyslipidemia, and hypertension are modifiable components of metabolic syndrome that would reduce morbidity and mortality of COVID-19,” conclude the investigators.

Source: Read Full Article

Related posts:
  1. New study describes which cancer patients are more vulnerable to COVID-19
  2. Have to wear sanitary pad with diaper for hours: Female doctors on challenges of wearing PPE
  3. Scientist unveils a 3-D printed device to excite nerves
  4. Only 15% of unemployed adults in NC gained Medicaid coverage during the pandemic, finds study